BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dedania B, Wu GY. Dermatologic Extrahepatic Manifestations of Hepatitis C. J Clin Transl Hepatol. 2015;3:127-133. [PMID: 26357639 DOI: 10.14218/jcth.2015.00010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Fiore M, Leone S, Maraolo AE, Berti E, Damiani G. Liver Illness and Psoriatic Patients. Biomed Res Int 2018;2018:3140983. [PMID: 29546055 DOI: 10.1155/2018/3140983] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
2 Arora S, Young S, Kodali S, Singal AK. Hepatic porphyria: A narrative review. Indian J Gastroenterol 2016;35:405-18. [PMID: 27796941 DOI: 10.1007/s12664-016-0698-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
3 Mohammad S, Chandio B, Soomro AA, Lakho S, Ali Z, Shaukat F. The Frequency of Cutaneous Manifestations in Hepatitis C: A Cross-sectional Study in a Tertiary Care Hospital in Pakistan. Cureus 2019;11:e6109. [PMID: 31777699 DOI: 10.7759/cureus.6109] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Ferreira GSA, Watanabe ALC, Trevizoli NC, Jorge FMF, Diaz LGG, Araujo MCCL, Araujo GC, Machado AC. Leukocytoclastic vasculitis caused by hepatitis C virus in a liver transplant recipient: A case report. World J Hepatol 2019; 11(4): 402-408 [PMID: 31114644 DOI: 10.4254/wjh.v11.i4.402] [Reference Citation Analysis]
5 Hegab DS, Sweilam MA. Cryoglobulinaemia in Egyptian Patients with Extrahepatic Cutaneous Manifestations of Chronic Hepatitis C Virus Infection. Dermatol Res Pract 2015;2015:182609. [PMID: 26839534 DOI: 10.1155/2015/182609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
6 Al-Bari MAA. Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases. Pharmacol Res Perspect 2017;5:e00293. [PMID: 28596841 DOI: 10.1002/prp2.293] [Cited by in Crossref: 182] [Cited by in F6Publishing: 177] [Article Influence: 36.4] [Reference Citation Analysis]
7 Ansari U, Henderson LI, Stott G, Parr K. Treatment with ledipasvir-sofosbuvir for hepatitis C resulting in improvement of lichen planus. JAAD Case Rep. 2017;3:67-69. [PMID: 28229123 DOI: 10.1016/j.jdcr.2016.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
8 Kuna L, Jakab J, Smolic R, Wu GY, Smolic M. HCV Extrahepatic Manifestations. J Clin Transl Hepatol. 2019;7:172-182. [PMID: 31293918 DOI: 10.14218/jcth.2018.00049] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
9 Gill K, Ghazinian H, Manch R, Gish R. Hepatitis C virus as a systemic disease: reaching beyond the liver. Hepatol Int. 2016;10:415-423. [PMID: 26660706 DOI: 10.1007/s12072-015-9684-3] [Cited by in Crossref: 77] [Cited by in F6Publishing: 76] [Article Influence: 11.0] [Reference Citation Analysis]
10 Nakano T, Moriya K, Koike K, Horie T. Hepatitis C virus core protein triggers abnormal porphyrin metabolism in human hepatocellular carcinoma cells. PLoS One 2018;13:e0198345. [PMID: 29856826 DOI: 10.1371/journal.pone.0198345] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]